Envestnet Asset Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2K | Sell |
18,464
-466
| -2% | -$965 | ﹤0.01% | 4395 |
|
|
2025
Q1 | $41.6K | Buy |
18,930
+1,182
| +7% | +$2.6K | ﹤0.01% | 4302 |
|
|
2024
Q4 | $27.2K | Sell |
17,748
-10,092
| -36% | -$15.4K | ﹤0.01% | 4280 |
|
|
2024
Q3 | $55.4K | Buy |
27,840
+8,683
| +45% | +$17.3K | ﹤0.01% | 4173 |
|
|
2024
Q2 | $67.1K | Buy |
19,157
+1,158
| +6% | +$4.05K | ﹤0.01% | 4088 |
|
|
2024
Q1 | $49.9K | Buy |
17,999
+4,576
| +34% | +$12.7K | ﹤0.01% | 4108 |
|
|
2023
Q4 | $22.8K | Buy |
13,423
+3,291
| +32% | +$5.6K | ﹤0.01% | 4017 |
|
|
2023
Q3 | $10.4K | Buy |
+10,132
| New | +$10.4K | ﹤0.01% | 3994 |
|
|
2022
Q1 | – | Sell |
-11,796
| Closed | -$108K | – | 3990 |
|
|
2021
Q4 | $108K | Buy |
+11,796
| New | +$108K | ﹤0.01% | 3756 |
|
|
2020
Q1 | – | Sell |
-55,406
| Closed | -$1.3M | – | 3045 |
|
|
2019
Q4 | $1.3M | Buy |
55,406
+2,427
| +5% | +$57K | ﹤0.01% | 1859 |
|
|
2019
Q3 | $980K | Buy |
52,979
+4,247
| +9% | +$78.6K | ﹤0.01% | 1957 |
|
|
2019
Q2 | $906K | Sell |
48,732
-2,200
| -4% | -$40.9K | ﹤0.01% | 2013 |
|
|
2019
Q1 | $1.25M | Buy |
50,932
+6,047
| +13% | +$148K | ﹤0.01% | 1753 |
|
|
2018
Q4 | $1.16M | Buy |
+44,885
| New | +$1.16M | ﹤0.01% | 1639 |
|
|
2018
Q3 | – | Sell |
-1,337
| Closed | -$52K | – | 1856 |
|
|
2018
Q2 | $52K | Sell |
1,337
-2
| -0.1% | -$78 | ﹤0.01% | 2197 |
|
|
2018
Q1 | $37K | Buy |
+1,339
| New | +$37K | ﹤0.01% | 2227 |
|